Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
21.15 SEK | -1.86% | +6.82% | +36.80% |
05-08 | Transcript : Orexo AB, Q1 2024 Earnings Call, May 08, 2024 | |
04-17 | Orexo Expands, Extends US Patent for Nasal Anaphylaxis Treatment | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+36.80% | 69.37M | |
+15.23% | 78.22B | |
+8.25% | 8.84B | |
-12.05% | 5.07B | |
+53.66% | 4.82B | |
+11.63% | 4.2B | |
-23.67% | 2.28B | |
+10.21% | 2.28B | |
-32.35% | 2.12B | |
+21.04% | 2.2B |
- Stock Market
- Equities
- ORX Stock
- News Orexo AB
- Transcript : Orexo AB, Q2 2023 Earnings Call, Jul 18, 2023